Regulatory
MLR Comments: Friend or Foe?
When I tell people that I work in pharma marketing, I occasionally get a ...
The Impact Colorado’s New Prescription Drug Law Will Have on Marketers
The General Assembly of the State of Colorado recently enacted a statute aimed at ...
GDPR: Where We’ve Come, Where We are Going
Recently, I wrote about Google’s $57 million fine for violating the now one-year old ...
Marketing Laboratory Developed Tests
On April 4, 2019, the U.S. Food and Drug Administration issued a Warning Letter ...
Patients in Favor of New DTC TV Price Transparency Rule
Last month, the U.S. Department of Health and Human Services (HHS) finalized the new ...
MedCrypt Offers Easy to Implement Medical Device Security
The ability for someone to hack into a medical device, like a pacemaker, is ...
How Safe are Safe Harbor Regulations?
The phrase “no more rebates” and recent guidance from the Department of Health and ...
Sprint Through Real-Time Promo Review
Agility benefits the entire value chain process, from basic research to clinical development, to ...
Words & Functionalities Matter: FDA Regulation of Consumer Software and Apps
Today, understanding whether digital health software or apps are actively regulated as medical devices ...
From Capitol Hill to the Oval Office: What Washington Has in Store for Pharma and Healthcare Communications in 2019
With 71% of voters citing it as their foremost concern, healthcare was among the ...
Progress Toward an Ethical Mindset
Everyone agrees that industry must move from rules- to values-based decision-making to ensure compliance ...
Talking About Your Pipeline
Ahead of commercialization, companies developing drugs and medical devices communicate about their pipeline products ...
Optimize Content Quality Globally
With anticipated launches of novel therapies and increasing sales for currently marketed prescription products, ...
